title: Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
abstract: Cortistatin is a recently discovered neuropeptide that is structurally related to somatostatin, the classic inhibitor of growth hormone (GH) release. Cortistatin binds with high affinity to all five somatostatin receptors (sst1-5), and, like somatostatin, cortistatin inhibits in vivo GH release in man and rats. In this report, we compared the in vitro actions of cortistatin and somatostatin using primary pig pituitary cell cultures. In this species, we have previously reported that somatostatin not only inhibits GH-releasing hormone (GHRH)-stimulated GH release at high doses, but also stimulates basal GH release at low (pM) doses, a dual response that is markedly dependent on the subpopulation of pituitary somatotropes examined. Results reported herein demonstrate that cortistatin closely mimics the dose-dependent inhibitory and stimulatory effects of somatostatin on GH secretion. As cortistatin, unlike somatostatin, binds to the human receptor for ghrelin/GH secretagogs (GHS-R), we also investigated whether cortistatin stimulates GH release through this receptor by using a synthetic, short form of cortistatin, cortistatin-8 (CST8), which lacks the sst-binding capacity of full-length cortistatin but retains its GHS-R-binding capacity. Interestingly, CST8 stimulated GH release only at low doses (10(-15) M), and did not reduce GH secretion stimulated by GHRH, ghrelin, or low-dose, full-length cortistatin, yet it counteracted that induced by a nonpeptidyl GHS, L-163 255. Taken together, our results indicate that the dual, inhibitory and stimulatory effects of cortistatin on GH release closely parallel those of somatostatin and are probably mediated by the same receptor(s) and signaling pathway(s) for both peptides. Furthermore, they suggest that the pathway(s) activated by cortistatin (and somatostatin) to stimulate GH release are not initiated by GHS-R activation.
authors.affiliation: Department of Cell Biology, Physiology and Immunology, University of Córdoba, Campus de Rabanales, Edificio C-6, Planta 3, E-14014 Córdoba, Spain.
authors.forename: R M
authors.initials: RM
authors.lastname: Luque
authors.forename: J R
authors.initials: JR
authors.lastname: Peinado
authors.forename: F
authors.initials: F
authors.lastname: Gracia-Navarro
authors.forename: F
authors.initials: F
authors.lastname: Broglio
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
authors.forename: R D
authors.initials: RD
authors.lastname: Kineman
authors.forename: M M
authors.initials: MM
authors.lastname: Malagón
authors.forename: J P
authors.initials: JP
authors.lastname: Castaño
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D010455:Peptides / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D010880:Piperidines / Q000378:metabolism / Q000494:pharmacology; D010902:Pituitary Gland / Q000166:cytology; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D054440:Receptors, Ghrelin; D015398:Signal Transduction / Q000502:physiology; D013004:Somatostatin / Q000235:genetics / Q000378:metabolism*; D052683:Somatotrophs / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D013141:Spiro Compounds / Q000378:metabolism / Q000494:pharmacology; D013552:Swine
chemical_list: D009479:Neuropeptides; D010455:Peptides; D010880:Piperidines; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin; D013141:Spiro Compounds; C099323:cortistatin; C102119:L 163255; D013004:Somatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone